| Lastest Insider Transactions Of G1 Therapeutics, Inc. ( GTHX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| GTHX | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | 2024-03-18 | Sell | 6,547 | 3.02 | 19,752 | 2024-03-20 16:32:31 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2024-02-12 | Sell | 28,600 | 4.62 | 132,143 | 2024-02-13 18:14:36 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2024-02-12 | Option Exercise | 28,600 | 0.30 | 8,580 | 2024-02-13 18:14:36 |
| GTHX | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | 2024-01-03 | Sell | 743 | 3.09 | 2,298 | 2024-01-08 06:04:31 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2024-01-03 | Sell | 3,740 | 3.08 | 11,537 | 2024-01-08 06:03:20 |
| GTHX | G1 Therapeutics, Inc. | Perry Andrew | Chief Commercial Officer | 2024-01-03 | Sell | 2,413 | 3.12 | 7,526 | 2024-01-08 06:03:09 |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | 2024-01-03 | Sell | 11,686 | 3.12 | 36,447 | 2024-01-08 06:02:52 |
| GTHX | G1 Therapeutics, Inc. | Avagliano Mark | Chief Business Officer | 2024-01-03 | Sell | 4,081 | 3.09 | 12,601 | 2024-01-08 06:02:02 |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | 2024-01-03 | Sell | 3,740 | 3.08 | 11,537 | 2024-01-08 06:00:43 |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | 2024-01-02 | Sell | 32,983 | 3.27 | 108,006 | 2024-01-02 19:44:10 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2023-12-11 | Sell | 33,839 | 3.41 | 115,522 | 2023-12-13 16:45:43 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2023-12-11 | Option Exercise | 33,839 | 0.36 | 12,081 | 2023-12-13 16:45:43 |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Directior | 2023-08-08 | Sell | 60,000 | 2.00 | 119,974 | 2023-08-10 16:11:04 |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Directior | 2023-08-08 | Option Exercise | 60,000 | 0.39 | 23,156 | 2023-08-10 16:11:04 |
| GTHX | G1 Therapeutics, Inc. | Perry Andrew | Chief Commercial Officer | 2023-07-05 | Sell | 355 | 2.45 | 871 | 2023-07-07 16:08:28 |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | 2023-07-05 | Sell | 1,361 | 2.45 | 3,339 | 2023-07-07 16:08:14 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2023-07-05 | Sell | 1,361 | 2.45 | 3,339 | 2023-07-07 16:08:02 |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | 2023-07-05 | Sell | 2,719 | 2.45 | 6,672 | 2023-07-07 16:07:39 |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | 2023-01-03 | Sell | 2,368 | 5.52 | 13,080 | 2023-01-05 20:26:25 |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | 2023-01-03 | Sell | 2,368 | 5.52 | 13,080 | 2023-01-05 20:26:17 |
| GTHX | G1 Therapeutics, Inc. | Perry Andrew | Chief Commercial Officer | 2023-01-03 | Sell | 820 | 5.58 | 4,572 | 2023-01-05 20:25:59 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2023-01-03 | Sell | 2,368 | 5.52 | 13,080 | 2023-01-05 20:25:49 |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | 2023-01-03 | Sell | 2,368 | 5.52 | 13,080 | 2023-01-05 20:25:32 |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | 2023-01-03 | Sell | 37,626 | 5.81 | 218,714 | 2023-01-05 20:23:54 |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | 2022-12-15 | Option Exercise | 14,000 | 0.30 | 4,200 | 2022-12-16 16:12:26 |
